Three-plane CCI comparable with single-plane outcomes

Article

The 2.75 mm three-plane clear corneal incision (CCI) created with a femtosecond (FS) laser produces comparable outcomes to single-plane angled manual incision for anterior and posterior corneal topography, claims a new study.

The 2.75 mm three-plane clear corneal incision (CCI) created with a femtosecond (FS) laser produces comparable outcomes to single-plane angled manual incision for anterior and posterior corneal topography, claims a new study.

Dr Marco Lombardo et al., Fondazione G.B. Bietti IRCCS, Rome, Italy, performed inflation testing in 14 human eye globes to assess the topographic response to the cornea to CCIs.

The eyes were divided into two group, with first group undergoing a 2.75 mm three-plane CCI created with an FS laser and the control group receiving a 2.75 mm manual CCI using disposable angled knives.

A Scheimpflug topographer was used to obtain topographic maps of the anterior and posterior cornea, keratometric data was used to evaluate the curvature changes of the cornea and vector analysis was used to identify the changes of corneal astigmatism.

The mean postoperative change of the anterior keratometric power was 0.04 ± 0.39 and 0.05 ± 0.51 in the FS laser and control groups, respectively and the mean change of the posterior corneal keratometric power was 0.16 ± 0.19 and 0.15 ± 0.18 D, respectively.

It was found that the average change of the anterior and posterior corneal astigmatism vector magnitude was 0.17 D or less in both groups. The team also recorded an insignificant against-the-rule astigmatic change in the anterior and posterior corneal interfaces after both CCI techniques.

To read the abstract please visit the Journal of Refractive Surgery.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.